Biochemical pharmacologyAug 4, 2026

RIPK3's structure, unusual roles in different situations, and precise treatment possibilities beyond cell death

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗

Updated Aug 5, 2026

Abstract

RIPK3 is recognized for its role in necroptosis but also regulates various cellular processes.

RIPK3 influences metabolic processes, inflammatory signaling, organelle maintenance, and stress responses through both kinase-dependent and independent pathways.
Activation of RIPK3 involves complex assembly through specific protein interactions, structural changes, and various modifications that affect signaling outcomes.
Structural studies have identified targetable conformations within the RIPK3 kinase domain that can influence downstream signaling beyond mere inhibition of its activity.
Non-canonical roles of RIPK3 include involvement in mitochondrial function, regulation of inflammasomes, autophagy, cellular aging, and immune responses.
The biological impact of RIPK3 can vary, contributing to either tissue protection or harmful inflammation based on the cellular environment and metabolic context.
Emerging therapeutic strategies focus on selectively targeting RIPK3 interactions and modifications to mitigate disease-related signaling while maintaining its normal functions.

Simplified

Receptor-interacting protein kinase 3 (RIPK3) is classically recognized as a central executor of necroptosis, but accumulating evidence indicates that its functions extend beyond lytic cell death. RIPK3 regulates metabolic processes, inflammatory signaling, organelle homeostasis, and stress responses through both kinase-dependent and kinase-independent mechanisms. In this review, we summarize the structural and regulatory basis of RIPK3 activation, including RIP homotypic interaction motif (RHIM)-mediated complex assembly, conformational regulation, and post-translational modification (PTM) networks that influence signaling outcomes. Recent structural and pharmacological studies have revealed druggable conformational states within the RIPK3 kinase domain and demonstrated that inhibitor-induced conformational changes can affect downstream signaling beyond catalytic inhibition. We further discuss non-canonical RIPK3 functions in mitochondrial metabolism, inflammasome regulation, autophagy, senescence, and immune regulation, highlighting the importance of cellular context, metabolic state, and signaling environment in determining RIPK3 activity. RIPK3 can therefore contribute to either tissue protection or pathological inflammation depending on the biological setting. Finally, we review emerging therapeutic strategies, including interaction-selective targeting, PTM-based modulation, cell-type-specific delivery, and conformation-selective inhibitor design, which aim to suppress disease-associated RIPK3 signaling while preserving its physiological functions.

Full Text

Full text is available at the source.

View Full Text ↗

RIPK3's structure, unusual roles in different situations, and precise treatment possibilities beyond cell death

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the longevity & aging brief